Search Results
Showing 10 from 131 results
What are Biologics and Biosimilars
We explain the difference between biologics and biosimilars and showcase Teva s innovative work in this space
Complex Generics Facts Figures and Who They Benefit
What are complex generic medicines and why are they important for patients We investigate the challenges involved in producing them and the conditions they are best suited to treat
3 Trends I m Watching in Pharmaceutical Marketing and Digital
Alyssa Fenoglio VP Global Head of Digital Commercial at Teva shares the key trends she s watching in her sector
Pivot to Growth The Teva Journey
Mapping the journey of Teva s Pivot to Growth strategy
Celebrating Pride Across the World
From colorful parades to a sense of belonging Teva people from the LGBTQIA community share their Pride experiences
Day in a Life Meet Bikalpa Lalchan
Bikalpa a Change Management Specialist from our CBMSO site in Salt Lake City Utah takes us through his dynamic day including collaborations with colleagues and a focus on Teva s values of Leading the way and Getting it done together
Can AI driven digital biomarkers redefine diagnostics and clinical trials
Artificial Intelligence and advanced analytics technologies have huge potential to improve the world of health We talk to Teva employees who are using the technologies
Breaking Boundaries How Diversity Fuels Innovation in Teva s R D Management Team
Meet Heather De Luca Head of Global Program Leadership R D Eric Hughes Head of Global R D and Chief Medical Officer and Sophie Lamle SVP Head of Innovative Medicines R D Together they offer valuable insights into how diversity particularly gender influences the development of groundbreaking ideas and solutions
Getting Medicines to All Who Need Them
The World Health Organization WHO estimates nearly two billion people do not have access to essential medicines especially vulnerable populations or people living in under resourced communities which means they can t afford or obtain the treatments they need